N-21
NDC 58264-0219, calcium fluoride, silicon dioxide, euphrasia stricta, ruta graveolens whole, gelsemium sempervirens whole, physostigma venenosum whole, anemone pulsatilla, sodium chloride, and sus scrofa eye, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0219
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0219 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CALCIUM FLUORIDE6 [hp_X]/mL
- SILICON DIOXIDE6 [hp_X]/mL
- EUPHRASIA STRICTA6 [hp_X]/mL
- RUTA GRAVEOLENS WHOLE6 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS WHOLE6 [hp_X]/mL
- PHYSOSTIGMA VENENOSUM WHOLE4 [hp_X]/mL
- ANEMONE PULSATILLA8 [hp_X]/mL
- SODIUM CHLORIDE12 [hp_X]/mL
- SUS SCROFA EYE200 [hp_X]/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0219-1 | 58264021901 | 29.57 mL in 1 BOTTLE, GLASS (58264-0219-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0219 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0219 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0219. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.